A detailed history of Brandes Investment Partners, LP transactions in Lensar, Inc. stock. As of the latest transaction made, Brandes Investment Partners, LP holds 330,948 shares of LNSR stock, worth $1.49 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
330,948
Previous 226,676 46.0%
Holding current value
$1.49 Million
Previous $795,000 41.51%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.25 - $5.0 $338,884 - $521,360
104,272 Added 46.0%
330,948 $1.13 Million
Q4 2023

Feb 09, 2024

BUY
$2.01 - $3.51 $13,722 - $23,962
6,827 Added 3.11%
226,676 $795,000
Q3 2023

Nov 13, 2023

BUY
$3.02 - $4.45 $121,488 - $179,014
40,228 Added 22.4%
219,849 $679,000
Q2 2023

Aug 11, 2023

BUY
$2.3 - $4.34 $32,137 - $60,642
13,973 Added 8.44%
179,621 $763,000
Q1 2023

May 10, 2023

BUY
$2.19 - $3.27 $362,769 - $541,668
165,648 New
165,648 $412,000
Q3 2022

Nov 14, 2022

BUY
$4.94 - $7.0 $34,827 - $49,350
7,050 Added 14.1%
57,033 $317,000
Q2 2022

Aug 12, 2022

BUY
$6.15 - $7.94 $43,111 - $55,659
7,010 Added 16.31%
49,983 $325,000
Q1 2022

May 10, 2022

BUY
$5.8 - $8.2 $86,988 - $122,983
14,998 Added 53.61%
42,973 $318,000
Q4 2021

Feb 11, 2022

BUY
$5.9 - $7.84 $566 - $752
96 Added 0.34%
27,975 $167,000
Q3 2021

Nov 12, 2021

BUY
$7.5 - $8.88 $46,050 - $54,523
6,140 Added 28.24%
27,879 $219,000
Q2 2021

Aug 11, 2021

BUY
$6.87 - $8.66 $40,958 - $51,630
5,962 Added 37.79%
21,739 $188,000
Q1 2021

May 14, 2021

SELL
$6.28 - $9.56 $1.77 Million - $2.7 Million
-282,063 Reduced 94.7%
15,777 $115,000
Q4 2020

Feb 11, 2021

BUY
$6.7 - $12.2 $2 Million - $3.63 Million
297,840 New
297,840 $2.06 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $49.6M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Brandes Investment Partners, LP Portfolio

Follow Brandes Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.